Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

News   Jun 30, 2017 | Original Story from the NIH

 
Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

Diaphragm muscle from SU9516 treated dystrophin deficient mouse showing nuclei (blue), myofibers (outlined in red) and regenerating muscle fibers (green). Credit: Burkin lab at the University of Nevada, Reno School of Medicine

 
 
 
 

RELATED ARTICLES

ACD/Labs Collaboration Provides NMR Data to Brazilian Biodiversity Natural Products Database

News

ACD/Labs announces collaboration with researchers at Brazilian Biodiversity database in support of chemical and pharmaceutical R&D.

READ MORE

Specific Gene Combinations Linked to Glioblastoma

News

A Yale-led team of researchers has identified specific gene combinations that can cause the deadly brain cancer glioblastoma, using new technology that can also pinpoint triggers of other types cancers.

READ MORE

A Promising Framework for Predicting Drug Resistance in Cancer

News

The system works by predicting the co-occurrence of about 500 known tumour alterations, as well as their response to over 200 common cancer drugs.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE